Innovation, Supply Chain Strengths Give GE Healthcare’s Wuxi Plant Competitive Edge
Miao Qi
DATE:  3 hours ago
/ SOURCE:  Yicai
Innovation, Supply Chain Strengths Give GE Healthcare’s Wuxi Plant Competitive Edge Innovation, Supply Chain Strengths Give GE Healthcare’s Wuxi Plant Competitive Edge

(Yicai) Nov. 17 -- Innovation and supply chain advantages have given GE Healthcare’s factory in Wuxi a competitive edge, prompting the US medical devices giant to manufacture more and more high-value components there, both for the Chinese and global markets.

“Our factory’s yield rate for ultrasound probes has exceeded 95 percent, while GE Healthcare’s other overseas factories are still only around 50 percent,” Cui Wei, general manager of GE Healthcare’s Wuxi production base, told Yicai.

Thanks to its clear yield advantage, the Wuxi plant produces about 50 percent of GE Healthcare’s global ultrasound probes, driving its overall capacity to grow at a double-digit rate each year, he said.

Twenty years ago, the Wuxi factory could handle only the back end of probe assembly, which required relatively lower technical expertise, Cui explained. As local engineering capabilities improved, GE Healthcare shifted the plant’s production to make transducers, a core probe component.

“The transducers produced at the Wuxi base have the best quality among all GE Healthcare factories worldwide, and they are also the most cost-efficient to make,” Cui noted.

This efficiency advantage comes not only from the Wuxi plant’s own operations, but also from the supply chain strengths of the surrounding Yangtze River Delta region. In fact, more than 95 percent of its supply chain is sourced locally, and the industrial chain is highly concentrated, with more than 400 suppliers clustered within a 200-kilometer radius, Cui pointed out.

For example, hardware from a supplier in Changzhou, when integrated with GE Healthcare’s self-developed artificial intelligence software, ensures fixture flatness in one-step probe manufacturing. The solution is now fully applied at the Wuxi plant, and the production process no longer relies on employees’ visual judgment.

Thanks to its advanced technology and strong cost control, the Wuxi factory is encouraging the above supplier to set up production bases overseas to provide solutions for GE Healthcare’s plants abroad, Cui added.

The Wuxi plant has developed more than 90 innovative products, accounting for nearly half of GE Healthcare’s China-developed products, supplies about 40 percent of the company’s global ultrasound systems and 50 percent of its probes, and has shipped a total of 2.8 million ultrasound systems and probes to more than 100 countries and regions, said Sun Xuguang, chief technology officer of GE Healthcare China.

More and more new product development and large-scale manufacturing tasks are shifting from overseas factories to the Wuxi base, Sun revealed, adding that over one-third of employees at the Wuxi base are now research and development staffers.

Editors: Tang Shihua, Futura Costaglione

Follow Yicai Global on
Keywords:   Innovation Advantage,Supply Chain Advantage,Yangtze River Delta Region,High-end Components,High-end Medical Devices,Wuxi Base,GE HealthCare